Source: Annual Congress 2010 - Pathology of lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
K. Tanaka, W. Shuo, M. Takeshita, M. Izumi, K. Takayama, Y. Nakanishi (Fukuoka, Japan). Enhanced expression of nicotinic alpha-1 acetylcholine receptor in lung cancer. Eur Respir J 2010; 36: Suppl. 54, 3268

Member's Comments

No comment yet.

Related content which might interest you: Muscarinic receptors mediate up-regulation of endothelin-1 expression in human lung fibroblasts Source: Annual Congress 2010 - Regulation of airway pharmacology Year: 2010 Histamine receptors in lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 812s Year: 2006 Hypoxia-mediated alterations in adenosine receptor expression in rat lung Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011 Increased relaxation of immature airways to beta-2 agonists is related to the attenuated expression of postjunctional smooth muscle muscarinic M2 receptors Source: Annual Congress 2004 - Understanding the complexity of how airways are regulated Year: 2004 The antitussive effects of alpha7 (a7) nicotinic receptor agonists Source: International Congress 2017 – Novel studies on bronchodilators and cough Year: 2017 Modulation of cortical and respiratory activity by 5-HT2 receptor agonist in the rat Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep Year: 2008 Potential role of memantine in the prevention and treatment of COVID-19: its antagonism of nicotinic acetylcholine receptors and beyond Source: Eur Respir J, 56 (2) 2001610; 10.1183/13993003.01610-2020 Year: 2020 Nicotinic alpha-7 receptor stimulation (a7nAChR) inhibited NF-kB/STAT3/SOCS3 pathways in a murine model of asthma. Source: International Congress 2017 – Novel mechanisms and treatments for asthma Year: 2017 Insulin acutely potentiates M3 muscarinic receptor function in rat and human airway smooth muscle Source: International Congress 2017 – Therapeutic approaches in lung disease Year: 2017 Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis Source: International Congress 2019 – Damage and remodelling in pulmonary fibrosis Year: 2019 Expression and functional involvement of muscarinic receptor 3 (M3) in human lung fibroblasts in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 121s Year: 2005 Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice Source: Eur Respir J 2008; 32: 426-436 Year: 2008 Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjects Source: Eur Respir J 2008; 31: 311-319 Year: 2008 In vivo potent and long-lasting bronchodilator activity of muscarinic M3 receptor antagonist CHF5407 Source: Eur Respir J 2007; 30: Suppl. 51, 26s Year: 2007 Vasopressin is involved in endothelin receptor antagonist-induced fluid retention in rat. Differential effect of selective ETA and dual ETA/ETB receptor antagonists Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments Year: 2012 Potentiation effect of insulin on M3 muscarinic receptor agonist induced airway smooth muscle contraction Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets Year: 2019 Characterising the cardiovascular safety profile of inhaled muscarinic receptor antagonists Source: Eur Respir Monogr 2020; 88: 238-250 Year: 2020 Muscarinic receptors mediate stimulation of collagen synthesis in human lung fibroblasts Source: Eur Respir J 2008; 32: 555-562 Year: 2008 Expression of endothelin receptor subtypes in different pulmonary tumours Source: Eur Respir J 2005; 26: Suppl. 49, 456s Year: 2005 Pharmacological activities of R-113281, a triple NK1 /NK2 /NK3 neurokinin receptor antagonist Source: Eur Respir J 2001; 18: Suppl. 33, 264s Year: 2001